logo

For the Inventor, By the Inventor

Vosselaar, Belgium

Marcel J Van Der Aa

USPTO Granted Patents = 27

Average Co-Inventor Count = 3.7

ph-index = 11

Forward Citations = 386(Granted Patents)


Location History:

  • Vosselaar, BE (1976 - 1985)
  • Kasterlee, BE (1991 - 1994)
  • Turnhout, BE (1997 - 1999)

Company Filing History:

goldMedal27 out of 2,079 
 
Janssen Pharmaceutica Nv
 patents

Years Active: 1976-1999

Loading Chart...
27 patents (USPTO):Explore Patents
1. 5985878 - Angiogenesis inhibiting pyridazinamines (1999-11-16),
2. 5811426 - Urea and thiourea derivatives of azolones (1998-09-22),
3. 5650411 - Substituted azolone derivatives (1997-07-22),
4. 5639754 - Urea and thiourea derivatives of azolones (1997-06-17),
5. 5292738 - Anti-virally active pyridazinamines (1994-03-08),
6. 5231184 - Pridazinamine derivatives (1993-07-27),
7. 5157035 - Anti-virally active pyridazinamines (1992-10-20),
8. 5112825 - Antirhinoviral heteroamine-substituted pyridazines (1992-05-12),
9. 5106973 - Pyridzainamine derivatives (1992-04-21),
10. 5070090 - Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers (1991-12-03),
11. 5001125 - Anti-virally active pyridazinamines (1991-03-19),
12. 4992433 - Novel pyridazinamine derivatives (1991-02-12),
13. 4522945 - (Piperidinylalkyl) quinazoline derivatives (1985-06-11),
14. 4377578 - Piperazine derivatives (1983-03-22),
15. 4335127 - Piperidinylalkyl quinazoline compounds, composition and method of use (1982-06-15),

Title: Innovations of Marcel J Van der Aa in Pharmaceutical Patents

Introduction

Marcel J Van der Aa, based in Vosselaar, Belgium, is an accomplished inventor known for his contributions to the field of pharmaceuticals. With a remarkable portfolio of 27 patents, he has made significant advancements in drug development, particularly focusing on novel compounds that exhibit therapeutic potential.

Latest Patents

One of his most notable recent inventions is related to "Angiogenesis inhibiting pyridazinamines." This invention pertains to compounds characterized by complex formulas that include N-oxide forms, pharmaceutically acceptable acid addition salts, and various stereochemical isomers. These innovative compounds may provide essential interventions in angiogenesis, a process that plays a critical role in various diseases. The invention elaborates on structural possibilities and functional groups, highlighting its importance in medicinal chemistry.

Another patent involves "Urea and thiourea derivatives of azolones," showcasing his continuous commitment to exploring diverse chemical avenues towards effective pharmaceutical solutions. These patents reflect his dedication to researching and developing new therapeutic modalities.

Career Highlights

Marcel J Van der Aa has notably aligned his career with Janssen Pharmaceutica NV, a leading company renowned for its research in pharmaceutical innovations. His role in this distinguished organization underscores his expertise and commitment to advancing medical science. His continual contributions reinforce his reputation as a leading inventor in the pharmaceutical industry.

Collaborations

Throughout his career, Marcel has collaborated with esteemed colleagues such as Jan Vandenberk and Albert H Van Heertum. These partnerships facilitate knowledge sharing and foster innovative approaches to complex problems within medical research. The synergy between these minds undoubtedly enriches the development of groundbreaking pharmaceutical inventions.

Conclusion

Marcel J Van der Aa stands out as a prominent figure in the realm of pharmaceutical innovations. His extensive portfolio and successful patents demonstrate a robust commitment to improving healthcare through research. With continued collaboration and innovation, he is poised to make an enduring impact in the field of medicines and therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…